Why Endocrinologists Get Sued: The Insulin Dose, the Missed Thyroid Cancer, and the Adrenal Crisis

By John Mahoney · June 2026 · 8 min read

Endocrinology is a cognitive, lab-driven specialty, and its malpractice exposure looks nothing like a procedural field. The cases rarely turn on a slip of the scalpel; they turn on a number on a lab report that was misread, mistimed, or never acted on — an insulin dose that drove a patient into severe hypoglycemia, a thyroid nodule that was a malignancy, an adrenal crisis that looked like a viral illness. Because the harm is metabolic and often delayed, these files reward an attorney who can follow a chain of values across visits rather than point to a single dramatic event. This guide explains where endocrinology liability actually lives, the cannot-miss failures behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The patterns below draw on closed-claims and insurer datasets that span different eras and definitions; treat them as directional, verify against the controlling jurisdiction, and value any individual case on its own record.

The Frequency-and-Severity Reality

By frequency, endocrinology sits toward the lower end of the specialty spectrum. It is a predominantly outpatient, cognitive specialty without the operative volume that drives claim counts in the surgical fields, and its annual claim frequency is commonly reported below the all-specialty average. Cumulative career risk is still real — most physicians in lower-risk specialties face a claim before retirement — but the year-to-year exposure is modest compared with high-risk procedural specialties.

Severity, however, is a different story, because the underlying conditions are life-altering when they go wrong. A severe hypoglycemic event can cause permanent neurologic injury or death; a missed thyroid cancer can metastasize during the delay; an unrecognized adrenal crisis can be rapidly fatal. As a result, the highest-payout endocrinology claims — the diabetes-management catastrophes and the missed-malignancy cases — carry damages that are entirely out of proportion to the specialty's low claim frequency. The screening lesson is that endocrinology is a low-frequency, high-severity profile: few claims, but the ones with merit can be very large, and they hinge on whether someone tracked and acted on a number.

The Dominant Allegation Types

Endocrinology claims cluster around diagnosis, management, and medication, with abnormal-lab follow-up running through all three:

• Diagnostic error — missed or delayed diagnosis — commonly the largest category by severity, dominated by missed or delayed thyroid cancer and unrecognized endocrine emergencies such as adrenal crisis, thyroid storm, and diabetic ketoacidosis.
• Improper management of treatment — mismanaged diabetes, including insulin titration and failure to prevent or monitor end-organ complications, and mismanaged thyroid or adrenal replacement.
• Medication errors — insulin dosing errors driving hypoglycemia, steroid and corticosteroid complications, and contraindicated prescribing such as metformin in renal impairment.
• Failure to monitor / failure to track and act on abnormal labs — the closed-loop result-notification failure that sits underneath many of the diagnostic and management claims.
• Lack of informed consent / failure to communicate — inadequate counseling on hypoglycemia risk, long-term steroid risk, and the need for follow-up testing.

The structural point: endocrinology is not a procedural-injury specialty. Its claims are built out of judgment, titration, and follow-up, and almost every meritorious file can be traced back to a value — a glucose, a TSH, a cortisol, a calcium — that was either wrong, ignored, or never relayed.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive endocrinology litigation are:

• Diabetes management — insulin dosing errors and severe hypoglycemia. The highest-volume management exposure. Over-aggressive insulin titration, failure to adjust for renal function, illness, or reduced intake, and inadequate hypoglycemia counseling can produce a severe hypoglycemic event with permanent neurologic injury. The mirror image is uncontrolled hyperglycemia progressing to diabetic ketoacidosis, plus failure to monitor and prevent end-organ complications (renal, retinal, neuropathic, cardiovascular). Medication-management errors such as metformin continued in renal impairment belong here as well.
• Thyroid — missed or delayed malignancy. A suspicious or growing nodule that was not worked up, a misread biopsy, or a malignancy attributed to benign disease. Also in this group: mismanaged thyroid storm and severe untreated hypothyroidism progressing to myxedema.
• Adrenal — missed insufficiency and crisis. Unrecognized adrenal insufficiency / adrenal crisis (including failure to stress-dose steroids), missed pheochromocytoma, and missed or mismanaged Cushing's syndrome.
• Failure to diagnose endocrine emergencies — the time-critical events (DKA, thyroid storm, adrenal crisis, myxedema coma) where delay rather than misdiagnosis drives the harm.
• Osteoporosis and calcium / parathyroid mismanagement — missed hyperparathyroidism, mismanaged hypercalcemia, and untreated osteoporosis leading to fracture, plus steroid- and insulin-related medication complications.

For the diagnostic and management sides alike, the single most actionable screening question is the closed-loop question: was the abnormal lab — the glucose, the TSH, the cortisol, the calcium, the biopsy result — seen, reported to the patient, and acted on? An endocrinology claim very often turns on a result-notification or recall failure rather than a defensible difference in clinical judgment.

The Contributing Factors That Drive Payouts

Across endocrinology closed claims, the recurring contributing factors are:

• Clinical judgment / diagnostic process — the costliest factor: failure to recognize an endocrine emergency, failure to work up a suspicious thyroid nodule, and anchoring on a benign explanation while a malignancy or adrenal crisis progresses.
• Medication and dosing management — insulin titration errors producing severe hypoglycemia, long-term steroid complications, failure to stress-dose, and contraindicated prescribing such as metformin in renal impairment.
• Failure to monitor and act on abnormal labs — the closed-loop failure: a critical glucose, TSH, cortisol, or calcium that was resulted but not relayed, not repeated, or not acted on. This is the single most decisive factor in whether a claim is paid.
• Communication and informed consent — failure to counsel on hypoglycemia risk, steroid risk, or the need for follow-up testing, and failure to coordinate with the primary-care physician or hospitalist managing the same patient.
• Documentation — incomplete records of dose changes, the rationale for titration, abnormal-result follow-up, and patient counseling that weaken the defense.

Two of these are endocrinology-specific levers. The first is the abnormal-lab closed loop: because the specialty runs on serial values, the line between a defensible file and a paid claim is usually whether the chart shows the critical result was tracked, reported, and acted on. The second is the co-management seam: endocrine patients are routinely shared with primary care and hospital teams, and many cases turn on which physician owned the result and the follow-up. Documentation rarely creates liability here, but it consistently decides whether a claim is paid — and it is what resolves the ownership question.

Strong Case vs. Weak Case in Endocrinology Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes an endocrinology case strong (plaintiff) / dangerous (defense)

• A critical lab value — a dangerously low glucose, a markedly abnormal TSH, an elevated calcium, or a positive biopsy — that was resulted but never reported to the patient or acted on, a clean closed-loop failure.
• A suspicious or growing thyroid nodule that was documented but never worked up, with a malignancy diagnosed later at a stage where earlier action carried a materially better prognosis, supporting a loss-of-chance causation theory.
• An insulin titration that ignored renal function, illness, or reduced intake and produced a severe hypoglycemic event with permanent neurologic injury, against thin documentation of dosing rationale and hypoglycemia counseling.
• An adrenal crisis, DKA, thyroid storm, or myxedema where the presentation was documented and the time-critical diagnosis was missed or delayed.

What makes an endocrinology case weak (plaintiff) / defensible (defense)

• A documented abnormal result with timely, recorded result-notification, appropriate repeat testing, and management — the closed loop intact.
• An insulin or steroid regimen with documented dosing rationale, hypoglycemia or steroid-risk counseling, and follow-up instructions, framing an adverse metabolic event as a disclosed, known risk rather than negligence.
• A patient whose record shows non-adherence, missed appointments, declined testing, or failure to report symptoms that drove the delay or the event.
• A condition managed to guideline standards with documented monitoring, clear allocation of follow-up between the endocrinologist and the primary or hospital team, and timely referral.

Endocrinology rewards a value-by-value reconstruction. On the diagnostic side, the case lives or dies on the closed loop and the loss-of-chance causation chain for the missed malignancy or emergency. On the management side, it turns on dosing rationale, monitoring, and the documented coordination among the physicians sharing the patient. Whichever side you are on, grading the file means tracing the critical labs across visits and pressure-testing the expert who will explain why a given number demanded a different action.

Bottom Line

Endocrinologists get sued rarely, but when a claim has merit it tends to be severe, because the underlying conditions — severe hypoglycemia, diabetic ketoacidosis, missed thyroid cancer, adrenal crisis — are catastrophic when they go wrong. The cannot-miss facts are the insulin dose that ignored renal function or intake, the suspicious thyroid nodule that was never worked up, the unrecognized adrenal or endocrine emergency, and above all the critical lab value that was resulted but never tracked, relayed, or acted on. Whether you are screening these cases for the plaintiff or defending them, reconstruct the chain of values across visits, fix who owned the result and the follow-up, and grade the file on the closed loop and the documented dosing and monitoring rationale, not on the severity of the outcome alone.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →